Septerna’s Post

Want to learn more about MOMA?

Last week, HCAP Partners' Ben C. participated in a panel at the Opus Connect Healthcare Conference in New York. The session, titled CEO Insights on Successful Exits, brought together private equity professionals and CEOs, including Anthony DeSena of HCAP portfolio company PAX Health, to discuss strategies for navigating exit planning in healthcare. Through a detailed case study and interactive Q&A, panelists explored the challenges and triumphs that shape successful outcomes. Thank you to moderator Michael Ritchie and all the panelists for an engaging discussion! #Healthcare #PrivateEquity #ExitPlanning

#Sundhedsaktier #GlobalHealthInvest Dear BioStock - Connecting Innovation and Capital and team. I really look forward to this session later today together with Andreas Dirnagl from DNB “Global Trends in Healthcare”. Have a great day ! /Claus Founder and CEO Global Health Invest ApS

In our latest episode of Trusts in Focus, we provide an overview of Bellevue Healthcare Trust, covering the trust's strategy, current portfolio and recent performance. Watch here: https://lnkd.in/dTzsY-GJ Capital at risk.

PitchBook's McGuireWoods LLP HCPE conference recap is out. Read the full report here: https://lnkd.in/g5eYAHXu >> More market activity is not yet translating into deal announcements. Processes are still long and halting. While the market is still waiting for the Fed to start cutting rates, sellers may bite the bullet and take a lower multiple if we continue to get "higher for longer" signals. >> As the BSL market reopens, the financing environment is becoming slightly more buyer friendly, especially in the upper half of the market. Dual processes are becoming more common. EBITDA and interest coverage remain the key areas of lender scrutiny. >> The antitrust environment is taking up a lot of mind share. >> PPMs have fallen so severely out of fashion that the current period was compared to the 1990s—an overstatement, but indicative of the market’s sentiment. >> Physician compensation is becoming even more challenging than usual as elongated holding times and margin compression erode the value of the “second bite.” >> Medspa is still hot, and we expect forward-thinking firms to increasingly integrate medspa with other women's health and wellness components such as concierge, HRT, weight loss >> Pharma services, especially trial sites, looks very competitive for this year

Gain valuable knowledge on health care transaction topics from renowned specialists in the 2024 Health Care Transactions Resource Guide. In this article, John Reiboldt from Coker discusses physician practice consolidation by private equity firms. Read the full article: https://bit.ly/3xGGana

Discover the keys to successful private equity transactions in healthcare with insights from MedEconomics. Dive into this article by Bert Orlov, Managing Director in EisnerAmper's Health Care Industry Group. https://okt.to/gTPYAu

Just Launched 🚀 PitchBook's recap of the McGuireWoods LLP #Healthcare #PrivateEquity conference, one of the two main healthcare PE conferences, with a focus on healthcare services in the core and lower middle market. ⭐ Here are some key takeaways: 🏥 The deal environment is more active than a year ago, but activity is not yet translating into announcements as deal processes move forward haltingly. 📉 The beginning of the Federal Reserve's rate-cutting cycle is likely to be the impetus for a serious resumption in deal activity, as we have maintained since last year. Further higher-for-longer signals could also prompt sellers to sell. 💳 The financing environment is becoming slightly more buyer-friendly, especially in the upper half of the market, as the broadly syndicated loan market reopens. EBITDA and interest coverage remain the key areas of lender scrutiny. 🏛 The antitrust environment was frequently mentioned in main-stage sessions, with many speakers pointing out PE's contribution to access and innovation in healthcare. However, those who needed to be convinced were not in the room. 💲 Physician compensation is becoming even more challenging than usual as elongated holding times and margin compression erode the value of the "second bite." 👂 Overheard in the pharma services session: "like a multisite physician practice deal but without all the hassle and with 10x the margin." Expect frothy valuations here in 2024. PPMs have fallen so severely out of fashion that the current period was compared to the 1990s—an overstatement but indicative of the market's sentiment. In the standing-room-only medspa session, two phrases uttered were "painfully fragmented" and "print cash." We are more interested in the consumer-driven wellness plays that might follow. #healthcare #privateequity #healthservices #finance #investing #antitrust #physiciancompensation #pharmaservices #consumerdrivenwellness

Discover the keys to successful private equity transactions in healthcare with insights from MedEconomics. Dive into this article by Bert Orlov, Managing Director in EisnerAmper's Health Care Industry Group. https://okt.to/FwSXU3

Mark your calendars for August 15 to hear about some recent scrutiny on private equity in the health care industry!